Hennion & Walsh Asset Management, Inc. - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 194 filers reported holding HERON THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.74 and the average weighting 0.2%.

Quarter-by-quarter ownership
Hennion & Walsh Asset Management, Inc. ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$583,000
+43.2%
138,200
-5.3%
0.04%
+52.0%
Q2 2022$407,000
-74.9%
146,008
-48.6%
0.02%
-70.9%
Q1 2022$1,624,000
-39.9%
283,954
-4.1%
0.09%
-35.3%
Q4 2021$2,703,000
-31.1%
296,052
-19.4%
0.13%
-35.4%
Q3 2021$3,924,000
-33.5%
367,117
-3.5%
0.21%
-34.6%
Q2 2021$5,901,000
-7.5%
380,242
-3.4%
0.32%
-17.8%
Q1 2021$6,378,000393,4810.38%
Other shareholders
HERON THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
TANG KEVIN C 760$783100.00%
Velan Capital Investment Management LP 6,986,744$7,196,3465.80%
Tejara Capital Ltd 2,109,681$2,172,9711.23%
JW Asset Management, LLC 2,407,418$2,479,6411.07%
Rubric Capital Management LP 26,713,503$27,514,9081.03%
GREAT POINT PARTNERS LLC 4,737,368$4,879,4890.89%
Orchard Capital Management, LLC 2,142,823$2,207,1080.82%
Clearline Capital LP 6,149,842$6,334,3380.54%
CM Management, LLC 450,000$463,5000.49%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 327,450$337,2740.48%
View complete list of HERON THERAPEUTICS INC shareholders